Statistics

Total Visits

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial38

Select a period of time:

Number of views in the range

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial28

Views

Views
February 20250
March 202513
April 20252
May 20252
June 20250
July 202511
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
Brazil6
United States4
Venezuela2
Spain1
United Kingdom1
Turkey1
 

Top cities views

Views
Abilene1
Barão de Cocais1
Bento Fernandes1
Caracas1
Ciudad Ojeda1
Confins1
Council Bluffs1
El Paso1
Myrtle Beach1
Porto Alegre1